Daniel J. Canney
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Daniel J. Canney has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Rong Gao
Moulder Center for Drug Discovery Research, Department of Pharmaceutical Sciences, Philadelphia, USA
4 shared publications- Richie Rashmin Bhandare
Center of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman P.O. Box 346, United Arab Emirates
3 shared publications Benjamin E. Blass
Department of Pharmaceuticals Sciences, Moulder Center for Drug Discovery Research, Temple University School of Pharmacy, Philadelphia, Pennsylvania, United States
2 shared publicationsJerome L. Gabriel
Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA
2 shared publicationsJohn C. Gordon
Department of Pharmaceuticals Sciences, Moulder Center for Drug Discovery Research, Temple University School of Pharmacy, Philadelphia, Pennsylvania, United States
2 shared publicationsKevin M. Blattner
Department of Pharmaceuticals Sciences, Moulder Center for Drug Discovery Research, Temple University School of Pharmacy, Philadelphia, Pennsylvania, United States
2 shared publications
Latest Publications
- Open Access
- 1 July 2024
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 327 (1) , G57-G69
Novel 5-HT7 receptor antagonists modulate intestinal immune responses and reduce severity of colitis
This study demonstrates that the novel highly selective 5-HT7 receptor antagonists, MC-170073 and MC-230078, significantly alleviated the severity of colitis across models of experimental colitis. These findings suggest that inhibition of 5-HT7 receptor signaling by these new antagonists may serve as an alternative mode of treatment to diminish symptomology in those with inflammatory bowel disease.
- 1 July 2024
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 327 (1) , G57-G69
Open AccessNovel 5-HT7 receptor antagonists modulate intestinal immune responses and reduce severity of colitis
This study demonstrates that the novel highly selective 5-HT7 receptor antagonists, MC-170073 and MC-230078, significantly alleviated the severity of colitis across models of experimental colitis. These findings suggest that inhibition of 5-HT7 receptor signaling by these new antagonists may serve as an alternative mode of treatment to diminish symptomology in those with inflammatory bowel disease.
- 29 December 2023
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 33 (2) , 287-297
Increased rigidity and bioisosteric replacement in the design, synthesis and preliminary evaluation of novel, functionalized 3,3-dialkyl-γ-butyrolactones as sigma-2 ligands
- 29 December 2023
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 33 (2) , 287-297
Increased rigidity and bioisosteric replacement in the design, synthesis and preliminary evaluation of novel, functionalized 3,3-dialkyl-γ-butyrolactones as sigma-2 ligands
- 29 July 2016
- Published by Bentham Science Publishers Ltd. in Medicinal Chemistry
- Vol. 12 (6) , 574-584
Ether and Carbamate Derivatives of 3-quinuclidinol and 3- hydroxymethylquinuclidine: Synthesis and Evaluation as Nicotinic Ligands
Background: A lead quinuclidine-based nicotinic ligand (EQA) served as the basis for the design of novel compounds. A new series of 3-substituted quinuclidines was designed, synthesized and evaluated as nicotinic ligands. Methods: The goal was to improve affinity for nicotinic receptors in the CNS. Interatomic distance calculations were performed on the proposed compounds as well as, known nicotinic ligands. The proposed compounds were then synthesized, characterized and evaluated in in vitro assays as nicotinic receptor ligands. Results: Compounds 9a and 9b were found to inhibit the specific binding of 3H-(S)-Nicotine with Ki values of 48 nM and 42 nM respectively, indicating high affinity interactions with the a4b2 subtype. Data suggest that several compounds act as partial agonists at CNS receptors with an efficacy between 28 and 40% and are potent partial activators of human muscle type receptors (a1b1gd; Emax= 80% that of 100 mM nicotine). Conclusions: Together these results indicate a partial agonism at muscle type receptors (ca. 40%) with no significant activation of rat ganglion-type receptors (a3b4*: asterisk indicates potential additional subunit that could partner to form the ganglionic receptor). The partial agonism inducing dopamine release from striatal synaptosomes (a4b2a6a4b2b3, and/or a6b2b3) suggest that these compounds may in addition be acting at the a4b2 and/or the a6b2b3* receptors. The partial agonists reported herein are interesting nicotinic ligands worthy of further investigation.
- 29 July 2016
- Published by Bentham Science Publishers Ltd. in Medicinal Chemistry
- Vol. 12 (6) , 574-584
Ether and Carbamate Derivatives of 3-quinuclidinol and 3- hydroxymethylquinuclidine: Synthesis and Evaluation as Nicotinic Ligands
Background: A lead quinuclidine-based nicotinic ligand (EQA) served as the basis for the design of novel compounds. A new series of 3-substituted quinuclidines was designed, synthesized and evaluated as nicotinic ligands. Methods: The goal was to improve affinity for nicotinic receptors in the CNS. Interatomic distance calculations were performed on the proposed compounds as well as, known nicotinic ligands. The proposed compounds were then synthesized, characterized and evaluated in in vitro assays as nicotinic receptor ligands. Results: Compounds 9a and 9b were found to inhibit the specific binding of 3H-(S)-Nicotine with Ki values of 48 nM and 42 nM respectively, indicating high affinity interactions with the a4b2 subtype. Data suggest that several compounds act as partial agonists at CNS receptors with an efficacy between 28 and 40% and are potent partial activators of human muscle type receptors (a1b1gd; Emax= 80% that of 100 mM nicotine). Conclusions: Together these results indicate a partial agonism at muscle type receptors (ca. 40%) with no significant activation of rat ganglion-type receptors (a3b4*: asterisk indicates potential additional subunit that could partner to form the ganglionic receptor). The partial agonism inducing dopamine release from striatal synaptosomes (a4b2a6a4b2b3, and/or a6b2b3) suggest that these compounds may in addition be acting at the a4b2 and/or the a6b2b3* receptors. The partial agonists reported herein are interesting nicotinic ligands worthy of further investigation.
- 7 January 2015
- Published by Georg Thieme Verlag KG in Synlett
- Vol. 26 (05) , 661-665
Synthesis of β,β-Disubstituted γ-Butyrolactones by Chemoselective Oxidation of 1,4-Diols and γ-Hydroxy Olefins with RuCl3/NaIO4
Substituted γ-butyrolactones represent an important group of structural fragments commonly found in natural products, receptor ligands, and drug molecules. Interest in preparing a library of substituted γ-butyrolactones and finding that limited routes to β-substituted lactones exist, led to the development of an efficient approach for the synthesis of β,β-disubstituted γ-butyrolactones. Readily prepared substituted 1,4-diols and γ-hydroxy olefins were treated with the RuCl3/NaIO4 oxidation system to provide the target β,β-disubstituted γ-butyrolactones in modest to good yields. The reaction goes through a lactol intermediate that was isolated and characterized for selected compounds. The approach supplies an efficient and versatile method for the synthesis of these important heterocyclic structures. Importantly, the present work is the first report that demonstrates the ability of RuCl3/NaIO4 to selectively oxidize primary hydroxyl groups in the presence of secondary alcohols to prepare lactones in good yields.
- 7 January 2015
- Published by Georg Thieme Verlag KG in Synlett
- Vol. 26 (05) , 661-665
Synthesis of β,β-Disubstituted γ-Butyrolactones by Chemoselective Oxidation of 1,4-Diols and γ-Hydroxy Olefins with RuCl3/NaIO4
Substituted γ-butyrolactones represent an important group of structural fragments commonly found in natural products, receptor ligands, and drug molecules. Interest in preparing a library of substituted γ-butyrolactones and finding that limited routes to β-substituted lactones exist, led to the development of an efficient approach for the synthesis of β,β-disubstituted γ-butyrolactones. Readily prepared substituted 1,4-diols and γ-hydroxy olefins were treated with the RuCl3/NaIO4 oxidation system to provide the target β,β-disubstituted γ-butyrolactones in modest to good yields. The reaction goes through a lactol intermediate that was isolated and characterized for selected compounds. The approach supplies an efficient and versatile method for the synthesis of these important heterocyclic structures. Importantly, the present work is the first report that demonstrates the ability of RuCl3/NaIO4 to selectively oxidize primary hydroxyl groups in the presence of secondary alcohols to prepare lactones in good yields.
- 1 April 2014
- Published by Bentham Science Publishers Ltd. in Medicinal Chemistry
- Vol. 10 (4) , 361-375
Bioisosteric Replacement and Related Analogs in the Design, Synthesis and Evaluation of Ligands for Muscarinic Acetylcholine Receptors
Abstract: Previous structure-activity relationship studies involving a series of lactone-based muscarinic ligands identified a lead compound containing a diphenylmethylpiperazine moiety (4; IC50 = 340 nM). The purpose of the present work is to investigate 1,3-benzodioxoles, 4,4-diethyl substituted tetrahydrofurans, 5-substituted oxazolidinones and chromones as bioisosteric replacements for the lactone ring in a novel series of muscarinic ligands. The approach provided compounds with improved % inhibition values and identified a non-selective muscarinic ligand with an IC50 value of 280 nM. The structure-activity relationship for this new series will be discussed. Selected compounds were evaluated in preliminary assays for subtype selectivity and were found to be non-selective.
- 1 April 2014
- Published by Bentham Science Publishers Ltd. in Medicinal Chemistry
- Vol. 10 (4) , 361-375
Bioisosteric Replacement and Related Analogs in the Design, Synthesis and Evaluation of Ligands for Muscarinic Acetylcholine Receptors
Abstract: Previous structure-activity relationship studies involving a series of lactone-based muscarinic ligands identified a lead compound containing a diphenylmethylpiperazine moiety (4; IC50 = 340 nM). The purpose of the present work is to investigate 1,3-benzodioxoles, 4,4-diethyl substituted tetrahydrofurans, 5-substituted oxazolidinones and chromones as bioisosteric replacements for the lactone ring in a novel series of muscarinic ligands. The approach provided compounds with improved % inhibition values and identified a non-selective muscarinic ligand with an IC50 value of 280 nM. The structure-activity relationship for this new series will be discussed. Selected compounds were evaluated in preliminary assays for subtype selectivity and were found to be non-selective.
- 22 August 2013
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 23 (2) , 1023-1030
Homologation as a lead modification approach en route to a series of lactone-based muscarinic ligands
- 22 August 2013
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 23 (2) , 1023-1030
Homologation as a lead modification approach en route to a series of lactone-based muscarinic ligands
- 23 September 2010
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 75 (21) , 7451-7453
A Versatile and Practical Microwave-Assisted Synthesis of Sterically HinderedN-Arylpiperazines
A wide-ranging and practical synthesis of structurally diverse, sterically hindered N-arylpiperazines from 2,2′-(4-nitrophenylsulfonylazanediyl) bis(ethane-2,1-diyl) bis(4-nitrobenzenesulfonate) and substituted anilines has been achieved using microwave irradiation in acetonitrile followed by deprotection with PhSH.
- 23 September 2010
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 75 (21) , 7451-7453
A Versatile and Practical Microwave-Assisted Synthesis of Sterically HinderedN-Arylpiperazines
A wide-ranging and practical synthesis of structurally diverse, sterically hindered N-arylpiperazines from 2,2′-(4-nitrophenylsulfonylazanediyl) bis(ethane-2,1-diyl) bis(4-nitrobenzenesulfonate) and substituted anilines has been achieved using microwave irradiation in acetonitrile followed by deprotection with PhSH.
- 6 April 2010
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 20 (5) , 558-565
Modifications to five-substituted 3,3-diethyl-4,5-dihydro-2(3H)-furanones en route to novel muscarinic receptor ligands
- 6 April 2010
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 20 (5) , 558-565
Modifications to five-substituted 3,3-diethyl-4,5-dihydro-2(3H)-furanones en route to novel muscarinic receptor ligands
- 1 February 2007
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 43 (3) , 1078-1085
Biotransformation of letrozole in rat liver microsomes: Effects of gender and tamoxifen
- 1 February 2007
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 43 (3) , 1078-1085
Biotransformation of letrozole in rat liver microsomes: Effects of gender and tamoxifen
- 1 July 2005
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 14 (5) , 241-259
Biososteric Replacement in the Design and Synthesis of Ligands for Nicotinic Acetylcholine Receptors
- 1 July 2005
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 14 (5) , 241-259
Biososteric Replacement in the Design and Synthesis of Ligands for Nicotinic Acetylcholine Receptors